Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Equity Average: 2017-2024

Historic Equity Average for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to $270.8 million.

  • Organogenesis Holdings' Equity Average fell 9.90% to $244.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $244.2 million, marking a year-over-year decrease of 9.90%. This contributed to the annual value of $270.8 million for FY2024, which is 0.51% down from last year.
  • As of FY2024, Organogenesis Holdings' Equity Average stood at $270.8 million, which was down 0.51% from $272.2 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Equity Average registered a high of $272.2 million during FY2023, and its lowest value of $98.7 million during FY2020.
  • For the 3-year period, Organogenesis Holdings' Equity Average averaged around $265.5 million, with its median value being $270.8 million (2024).
  • Per our database at Business Quant, Organogenesis Holdings' Equity Average spiked by 188.62% in 2020 and then fell by 0.51% in 2024.
  • Organogenesis Holdings' Equity Average (Yearly) stood at $98.7 million in 2020, then soared by 94.10% to $191.6 million in 2021, then skyrocketed by 32.33% to $253.5 million in 2022, then grew by 7.36% to $272.2 million in 2023, then dropped by 0.51% to $270.8 million in 2024.